Aarkstore - Glutamate Receptor Antagonists -Pipeline Insights, 2014

1
Glutamate Receptor Antagonists -Pipeline
Insights, 2014
Category Pharmaceuticals Healthcare 

• Browse Complete Report -
• http//www.aarkstore.com/pharmaceuticals-healthcar
  e/73728/glutamate-receptor-antagonists-pipeline-in
  sights-2014

2
Summary

• DelveInsights,Glutamate Receptor
  Antagonists-Pipeline Insights, 2014, report
  provides comprehensive insights about pipeline
  drugs across this mechanism of action (MOA). A
  key objective of the report is to establish the
  understanding for all the pipeline drugs that
  fall under Glutamate Receptor Antagonists. This
  report provides information on the therapeutic
  development based on the Glutamate Receptor
  Antagonists dealing with mechanism of action,
  comparative analysis at various stages covering
  Filed, Phase III, Phase II, Phase I, IND filed,
  Preclinical, Discovery and unknown stages,
  therapeutics assessment by monotherapy and
  combination products and molecule type drug
  information. The report also covers the companies
  information involved in the therapeutic
  development of the products. It also has
  highlighted the discontinued and dormant
  products. 

3
Summary

• Data SourcesThe report is built using data and
  information sourced from proprietary databases,
  primary and secondary research and in-house
  analysis by DelveInsight team of industry
  experts.Secondary sources information and data
  has been collected from various printable and
  non-printable sources like search engines, News
  websites, Government Websites, Trade Journals,
  White papers, Magazines, Trade associations,
  Books, Industry Portals, Industry Associations
  and access to available databases.Please note
  this report requires certain updates. We have all
  the information available but require 3 business
  days to complete the process and ensure it is as
  up-to-date as possible. Certain sections in the
  report may be removed or altered based on the
  availability and relevance of data for the
  indicated mechanism of action. 

4
Summary

• Scope The report provides a snapshot of the
  global therapeutic landscape of Glutamate
  Receptor AntagonistsThe report provides pipeline
  products under drug profile section which
  includes product description, MOA, licensors
  collaborators, development partner and chemical
  informationCoverage of the Glutamate Receptor
  Antagonists pipeline on the basis of target, MOA,
  route of administration, technology involved and
  molecule typeThe report reviews key players
  involved in the therapeutics development for
  Glutamate Receptor Antagonists and also provide
  company profilingThe report also gives the
  information of dormant and discontinued pipeline
  projects Pipeline products coverage based on
  various stages of development ranging from
  preregistration till discovery and undisclosed
  stages Provides pipeline assessment by
  monotherapy and combination therapy products,
  stage of development and molecule type

5
Summary

• Reasons to buyComplete MOA intelligence and
  complete understanding over therapeutics
  development for Glutamate Receptor
  AntagonistsIdentify the relationship between the
  drugs and use it for target finding, drug
  repurposing, and precision medicine.Devise
  corrective measures for pipeline projects by
  understanding Glutamate Receptor Antagonists
  pipeline depth and focus of Indication
  therapeutics Developing strategic initiatives to
  support your drug development activities.Optimize
  your portfolio and keep you in touch with the
  rapidly changing pharmaceutical markets, and make
  the best decisions for your business.

6
Report Methodology 

• Develop and design in licensing and out licensing
  strategies by identifying prospective partners
  with the most attractive projects to enhance and
  expand business potential and ScopeProvides
  strategically significant competitor information,
  analysis, and insights to formulate effective RD
  development strategies Modify the therapeutic
  portfolio by identifying discontinued projects
  and understanding the factors that drove them
  from pipeline Gaining a Full Picture of the
  Competitive Landscape for Evidence based Decisions

Browse Complete Report - http//www.aarkstore.com/
pharmaceuticals-healthcare/73728/glutamate-recepto
r-antagonists-pipeline-insights-2014
7
Table of Content

• Glutamate Receptor Antagonists OverviewGlutamate
  Receptor Antagonists Disease AssociatedGlutamate
  Receptor Antagonists Pipeline TherapeuticsGlutama
  te Receptor Antagonists Therapeutics under
  Development by Companies Glutamate Receptor
  Antagonists Late Stage Products (Filed and Phase
  III)Comparative Analysis Glutamate Receptor
  Antagonists Mid Clinical Stage Products (Phase
  II)Comparative Analysis Glutamate Receptor
  Antagonists Early Clinical Stage Products (Phase
  I and IND Filed)Comparative Analysis  Glutamate
  Receptor Antagonists Discovery and Pre-Clinical
  Stage Products Comparative Analysis Drug
  Candidate Profiles

8
List of Tables

• Number of Products under Development for
  Glutamate Receptor Antagonists by Therapy Area,
  2014Number of Products under Development for
  Glutamate Receptor Antagonists, 2014Number of
  Products under Development by Companies Comparati
  ve Analysis by Late Clinical Stage Products
  (Filed and Phase III), 2014Comparative Analysis
  Mid Clinical Stage Products (Phase II),
  2014Comparative Analysis Early Clinical Stage
  Products (Phase I and IND Filed),
  2014Comparative Analysis Discovery and
  Pre-Clinical Stage Products, 2014Drug Candidates
  ProfilesGlutamate Receptor Antagonists
  Assessment by Monotherapy Products Glutamate
  Receptor Antagonists Assessment by Combination
  Products Glutamate Receptor Antagonists
  Assessment by Route of Administration 

9
List of Tables

• Glutamate Receptor Antagonists Assessment by
  Stage and Route of Administration Glutamate
  Receptor Antagonists Assessment by Molecule
  Type Glutamate Receptor Antagonists Assessment
  by Stage and Molecule Type Glutamate Receptor
  Antagonists Therapeutics Discontinued
  Products Glutamate Receptor Antagonists
  Therapeutics Dormant ProductsProducts under
  Development by Companies, 2014

10
List of Figures

• Number of Products under Development for
  Glutamate Receptor Antagonists by Therapy Area,
  2014Number of Products under Development for
  Glutamate Receptor Antagonists, 2014Late
  Clinical Stage Products (Filed and Phase III),
  2014Mid Clinical Stage Products (Phase II),
  2014Early Clinical Stage Products (Phase I and
  IND Filed), 2014Discovery and Pre-Clinical Stage
  Products, 2014Glutamate Receptor Antagonists
  Assessment by Monotherapy Products Glutamate
  Receptor Antagonists Assessment by Combination
  Products Glutamate Receptor Antagonists
  Assessment by Route of Administration Glutamate
  Receptor Antagonists Assessment by Stage and
  Route of Administration Glutamate Receptor
  Antagonists Assessment by Molecule
  Type Glutamate Receptor Antagonists Assessment
  by Stage and Molecule Type

11
Related Reports

• OncoPlex Diagnostics - Pharmaceuticals
  Healthcare - Deals and Alliances Profile
• MetaStat, Inc. - Pharmaceuticals Healthcare -
  Deals and Alliances Profile
• Advanced Cell Diagnostics, Inc. - Pharmaceuticals
  Healthcare - Deals and Alliances Profile
• Recordati S.p.A. (REC) - Pharmaceuticals
  Healthcare - Deals and Alliances Profile
• Ascension Health - Pharmaceuticals Healthcare
  - Deals and Alliances Profile

12

• Glutamate Receptor Antagonists -Pipeline
  Insights, 2014
• Published Dec. 2014 60 Pages
• DelveInsights,Glutamate Receptor
  Antagonists-Pipeline Insights, 2014, report
  provides comprehensive insights about pipeline
  drugs across this mechanism of action (MOA).
  Price

Format Price
PDF 1250
Site Licence 2500
Enterprise Wide Licence 4000
13
Contact Us
Office Office No. - 809, 8th Floor,B-Wing,
Mahaavir Icon, Plot No.- 89 90,
Sector-15,CBD-Belapur, Navi Mumbai
400614, Maharashtra, India. Telefax No 91 22
4127 6660 24/7 Online Support 91
9987295242 General Inquiries 91 - 22 2756 4953

• You Can Visit http//www.aarkstore.com
• OR Mail us at contact_at_aarkstore.com
• Blog
• http//www.aarkstore.com/blog/
• Conference
• http//conference.aarkstore.com/
• News
• http//www.aarkstore.com/news